Сиркава

Сиркава contains anhydrous tiotropium bromide, a long-acting anticholinergic bronchodilator used to manage chronic obstructive pulmonary conditions. This medication helps open airways for easier breathing. Suitable for adults seeking maintenance therapy.

Сиркава is primarily used to relieve symptoms of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It helps reduce wheezing, shortness of breath, and chest tightness by relaxing airway muscles. The medication provides long-term control rather than quick relief during sudden breathing difficulties.

Users of Сиркава often report improved breathing comfort and reduced frequency of flare-ups over time. Some may experience a dry mouth or throat irritation shortly after use. These effects are generally mild and tend to diminish with regular use.

Keep Сиркава in a dry place away from direct sunlight to maintain its effectiveness. Always store it at room temperature and ensure the cap is tightly closed after each use. If irritation or persistent dryness occurs, consult a healthcare provider for advice.

Сиркава may interact with other anticholinergic medications, potentially increasing side effects like dry mouth or urinary retention. Combining it with certain inhaled corticosteroids or beta-agonists is common but should be monitored by a healthcare professional.